America’s Overspend: How the Pharmaceutical Patent Problem is Fueling High Drug Prices

25 Oct 2017
View Resource

The American health system is poised to incur $55 billion in excess costs from pharmaceutical companies’ strategies to delay competition on three drugs

Join us to stay updated
and help make lifesaving medicines accessible to all